These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38947422)

  • 1. Testing ethical impact assessment for nano risk governance.
    Malsch I; Isigonis P; Bouman E; Afantitis A; Melagraki G; Dusinska M
    Open Res Eur; 2023; 3():170. PubMed ID: 38947422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embedding Ethical Impact Assessment in Nanosafety Decision Support.
    Malsch I; Isigonis P; Dusinska M; Bouman EA
    Small; 2020 Sep; 16(36):e2002901. PubMed ID: 32700443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Governance of Nanomaterials: Review of Criteria and Tools for Risk Communication, Evaluation, and Mitigation.
    Isigonis P; Hristozov D; Benighaus C; Giubilato E; Grieger K; Pizzol L; Semenzin E; Linkov I; Zabeo A; Marcomini A
    Nanomaterials (Basel); 2019 May; 9(5):. PubMed ID: 31060250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empowering citizens in international governance of nanotechnologies.
    Malsch I; Subramanian V; Semenzin E; Hristozov D; Marcomini A; Mullins M; Hester K; McAlea E; Murphy F; Tofail SA
    J Nanopart Res; 2015; 17(5):215. PubMed ID: 25983616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to Nanomaterials.
    Isigonis P; Afantitis A; Antunes D; Bartonova A; Beitollahi A; Bohmer N; Bouman E; Chaudhry Q; Cimpan MR; Cimpan E; Doak S; Dupin D; Fedrigo D; Fessard V; Gromelski M; Gutleb AC; Halappanavar S; Hoet P; Jeliazkova N; Jomini S; Lindner S; Linkov I; Longhin EM; Lynch I; Malsch I; Marcomini A; Mariussen E; de la Fuente JM; Melagraki G; Murphy F; Neaves M; Packroff R; Pfuhler S; Puzyn T; Rahman Q; Pran ER; Semenzin E; Serchi T; Steinbach C; Trump B; Vrček IV; Warheit D; Wiesner MR; Willighagen E; Dusinska M
    Small; 2020 Sep; 16(36):e2003303. PubMed ID: 32700469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Essential Elements of a Risk Governance Framework for Current and Future Nanotechnologies.
    Stone V; Führ M; Feindt PH; Bouwmeester H; Linkov I; Sabella S; Murphy F; Bizer K; Tran L; Ågerstrand M; Fito C; Andersen T; Anderson D; Bergamaschi E; Cherrie JW; Cowan S; Dalemcourt JF; Faure M; Gabbert S; Gajewicz A; Fernandes TF; Hristozov D; Johnston HJ; Lansdown TC; Linder S; Marvin HJP; Mullins M; Purnhagen K; Puzyn T; Sanchez Jimenez A; Scott-Fordsmand JJ; Streftaris G; van Tongeren M; Voelcker NH; Voyiatzis G; Yannopoulos SN; Poortvliet PM
    Risk Anal; 2018 Jul; 38(7):1321-1331. PubMed ID: 29240986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAIRification of nanosafety data to improve applicability of (Q)SAR approaches: A case study on
    Bossa C; Andreoli C; Bakker M; Barone F; De Angelis I; Jeliazkova N; Nymark P; Battistelli CL
    Comput Toxicol; 2021 Nov; 20():100190. PubMed ID: 34820591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Workshop Report: Governance of Emerging Nanotechnology Risks in the Semiconductor Industry.
    Watjanatepin P; Castagnola V; Cetin Y; Linkov I; Skentelbery C; Prodanov D
    Front Public Health; 2020; 8():275. PubMed ID: 32733835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blueprint for a self-sustained European Centre for service provision in safe and sustainable innovation for nanotechnology.
    Marcoulaki E; López de Ipiña JM; Vercauteren S; Bouillard J; Himly M; Lynch I; Witters H; Shandilya N; van Duuren-Stuurman B; Kunz V; Unger WES; Hodoroaba VD; Bard D; Evans G; Jensen KA; Pilou M; Viitanen AK; Bochon A; Duschl A; Geppert M; Persson K; Cotgreave I; Niga P; Gini M; Eleftheriadis K; Scalbi S; Caillard B; Arevalillo A; Frejafon E; Aguerre-Chariol O; Dulio V
    NanoImpact; 2021 Jul; 23():100337. PubMed ID: 35559838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical issues: the multi-centre low-risk ethics/governance review process and AMOSS.
    Vaughan G; Pollock W; Peek MJ; Knight M; Ellwood D; Homer CS; Pulver LJ; McLintock C; Ho MT; Sullivan EA
    Aust N Z J Obstet Gynaecol; 2012 Apr; 52(2):195-203. PubMed ID: 22188386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ethics Ecosystem: Personal Ethics, Network Governance and Regulating Actors Governing the Use of Social Media Research Data.
    Samuel G; Derrick GE; van Leeuwen T
    Minerva; 2019 Sep; 57(3):317-343. PubMed ID: 31501635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of agriculture, nutrition and health researchers regarding research governance in Malawi. Using a leadership, ethics, governance and systems framework.
    Matandika L; Millar K; Umar E; Mfutso-Bengo J
    BMC Med Ethics; 2023 Aug; 24(1):66. PubMed ID: 37605143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical governance is essential to building trust in robotics and artificial intelligence systems.
    Winfield AFT; Jirotka M
    Philos Trans A Math Phys Eng Sci; 2018 Oct; 376(2133):. PubMed ID: 30323000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Governance and measures for the ethical and social aspects of biobanks].
    Iwae S; Masui T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):493-7. PubMed ID: 22504670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is It Time to Re-Evaluate the Ethics Governance of Social Media Research?
    Samuel G; Ahmed W; Kara H; Jessop C; Quinton S; Sanger S
    J Empir Res Hum Res Ethics; 2018 Oct; 13(4):452-454. PubMed ID: 30141738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of research to the responsible and sustainable development of nanotechnologies].
    Iavicoli S; Boccuni F
    G Ital Med Lav Ergon; 2008; 30(3 Suppl):110-4. PubMed ID: 19288800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-centre ethics and research governance review can impede non-interventional clinical research.
    Duplancic C; Crough T; Bell SC;
    Intern Med J; 2019 Jun; 49(6):722-728. PubMed ID: 30417974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsible, Inclusive Innovation and the Nano-Divide.
    Schroeder D; Dalton-Brown S; Schrempf B; Kaplan D
    Nanoethics; 2016; 10():177-188. PubMed ID: 27478517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an understanding of global brain data governance: ethical positions that underpin global brain data governance discourse.
    Ochang P; Eke D; Stahl BC
    Front Big Data; 2023; 6():1240660. PubMed ID: 38025947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.